| Novartis Pharma Schweiz AG - Desferal, Pulver zur Herstellung einer Injektions-/Infusionslösung |
| 29668 | | 01 | | Desferal | | Pulver zur Herstellung einer Injektions-/Infusionslösung | | V03AC01 | | Deferoxamine | | 03.06.1963 | | |
|
| Composition |
| Praeparatio cryodesiccata: deferoxamini mesilas 500 mg pro vitro. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Injection preparation | | | | | | | | Active Agent | Dose |
|---|
| Deferoxamine Mesylate | 500 mg |
| | BAG: Active Agent | Dose |
|---|
| Deferoxamine Mesylate | 500 mg |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 019 | 10 Durchstechflasche(n) | 50.81 | 71.65 | B | SL | Yes |
|
